NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Medicaments primarily affecting the central nervous system, put up in measured doses or in forms or packings for retail sale, nesoi
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
Q - Subject to damage from freezing
W - Rating variable
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $72.29 to $120.49.. | |
| Does NSN 6505-00-079-7611 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Kuwait, and Republic Of Korea | |
| What is the NIIN of NSN 6505-00-079-7611? | |
| 000797611 or 00-079-7611 | |
| Does NSN 6505-00-079-7611 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6505-00-079-7611? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Apr 29, 1972 | |
Ld50 lc50 mixture: oral ld50 (rat) is >5000 mg/kg
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute: exposure may cause eye
irritation or irritation to respiratory passages. Hypersensitivity
reactions may occur. However; adverse effects are not anticipated.
explanation of carcinogenicity: no ingredient of a concentration of 0.1%
or greater is listed as a carcinogen or suspected carcinogen.
effects of overexposure: urticaria, transient rash, dizziness, headache,
nausea, vomiting, chills, fever, nervousness, insomnia.
medical cond aggravated by exposure: exposure to this drug is
contraindicated in people with atopy or those with known or
suspected hypersensitivity to spectinomycin.
First aid: eyes-flush with water for 15 minutes, hold lids open.
skin-wash with soap and water. Remove contaminated clothes.
inhaled-remove from exposure. Ingested-cantact a physician or
poison control center.
Hcc: t6
melt/freeze pt: m.P/f.P text: 363f,184c
solubility in water: >20 mg/ml
appearance and odor: white crystalline powder (2g) in vials.
Stability indicator/materials to avoid: yes
none.
stability condition to avoid: none.
hazardous decomposition products: none.
Waste disposal methods: dispose of by incineration in accordance with
applicable international, national, state, and/or local waste
disposal regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: spectinomycin dihydrochloride pentahydrate
cas: 22189-32-8
rtecs #: wg7400000
fraction by wt: 100%
other rec limits: none recommended